Author:
Damm Steffen,Schwarz Elisabeth
Abstract
Abstract
Alternative folding or fibril formation of proteins is associated with many diseases. Although uncertainty remains for many diseases as to whether the fibrils themselves constitute the main pathogenicity factor, the biophysics or molecular steps leading to fibrils cannot easily be reduced to a common denominator. To date, it is known that fibrils can form (i) upon aberrant (over-)production or false processing, (ii) upon infection with prions that act as seeds and induce unfolding of a thus far native protein – as has been shockingly experienced during the bovine spongiform encephalopathy episode, (iii) when mutations are present that increase the propensity of an otherwise stable protein to aggregate, or (iv) when mutation decreases the overall stability of an individual protein. This review intends to highlight some of the biochemical and biophysical mechanisms that favor fibril formation. Special emphasis is given on the relevance of the polypeptide environment of amyloidogenic segments and the currently discussed driving forces of fibril formation.
Subject
Clinical Biochemistry,Molecular Biology,Biochemistry
Reference176 articles.
1. case of protease sensitive prionopathy in a patient in the UK;Head;Appl,2009
2. Experimental constraints on quaternary structure in Alzheimer s beta fibrils;Petkova;amyloid Biochemistry,2006
3. Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly binding protein aggregates which sequester poly;Calado;RNA Hum Mol Genet,2000
4. Increased susceptibility to Kuru of carriers of the methionine methionine genotype;Lee;Infect Dis,2001
5. Effect of oculopharyngeal muscular dystrophy - associated extension of seven alanines on the fibrillation properties of the terminal domain of;Lodderstedt;FEBS J,2007